Keyphrases
Alzheimer's Disease
100%
Disease Effects
100%
Blood-brain
100%
Brain Glucose
100%
GLP-1 Analogue
100%
Tmax
50%
Cerebral Glucose Metabolism
37%
Liraglutide
25%
Placebo
25%
Blood-brain Barrier
25%
Glucagon-like peptide-1 (GLP-1)
25%
Disease Duration
12%
Reduced Expression
12%
Matched Control Group
12%
Glucose Transport
12%
Glucose Transporter 1 (GLUT1)
12%
Disease Groups
12%
Age-matched
12%
Incretin Hormones
12%
Healthy Volunteers
12%
Therapeutic Target
12%
Cerebral Cortex
12%
Neuroscience
Alzheimer's Disease
100%
Glucose Transport
100%
Glucagon-Like Peptide-1
100%
Placebo
25%
Liraglutide
25%
Blood Brain Barrier
25%
Incretin
12%
Cerebral Cortex
12%
Glucose Transporter
12%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Glucagon-Like Peptide-1
100%
Liraglutide
25%
Placebo
25%
Blood-Brain Barrier
25%
Diseases
12%
Incretin
12%
Glucose Transporter
12%
Normal Human
12%